Dr. Hooman Noorchashm, surgeon and patient safety advocate, has written several letters to the U.S. Food and Drug Administration urging the agency to require pre-screening for SARS-CoV-2 viral proteins — which would be present in someone who has already been infected with COVID — in an effort to reduce COVID vaccine injuries and deaths.
According to Noorchasm, it is scientifically established that once a person is naturally infected by a virus, antigens from that virus persist in the body for a long time after viral replication has stopped and clinical signs of infection have resolved. When a vaccine reactivates an immune response in a recently infected person, the tissues harboring the persisting viral antigen are targeted, inflamed and damaged by the immune response.
J. Patrick Whelan M.D., Ph.D., expressed similar concern that COVID vaccines aimed at creating immunity against the SARS-CoV-2 spike protein could have the potential to cause microvascular injury to the brain, heart, liver and kidneys in a way that does not currently appear to be assessed in safety trials of these potential drugs.
Cartas del Dr. Hooman Noorchashm a la Administración de Drogas y Alimentos de EE. UU.
El Dr. Hooman Noorchashm, cirujano y defensor de la seguridad del paciente, ha escrito varias cartas a la Administración de Alimentos y Medicamentos de los EE. UU. Instando a la agencia a exigir un examen previo de las proteínas virales del SARS-CoV-2, que estarían presentes en alguien que ya ha sido infectado. con COVID, en un esfuerzo por reducir las lesiones y muertes por la vacuna COVID.
Según Noorchasm, está científicamente establecido que una vez que una persona es infectada naturalmente por un virus, los antígenos de ese virus persisten en el cuerpo durante mucho tiempo después de que se detiene la replicación viral y se resuelven los signos clínicos de la infección. Cuando una vacuna reactiva una respuesta inmune en una persona infectada recientemente, los tejidos que albergan el antígeno viral persistente son atacados, inflamados y dañados por la respuesta inmune.
J. Patrick Whelan MD, Ph.D., expresó una preocupación similar de que las vacunas COVID destinadas a crear inmunidad contra la proteína pico SARS-CoV-2 podrían tener el potencial de causar daño microvascular al cerebro, corazón, hígado y riñones de alguna manera que actualmente no parece estar evaluado en ensayos de seguridad de estos fármacos potenciales.
All vaccines should be immediately be suspended until all professional notifications are considered and complete studies reviewed by the FDA and all government leaders kept updated on the results.
Or until there is actually validated proof that they are safe instead of just being told that they are and to show that it even exists. They have not even proven the existence of a virus. Research and see that this is the case, even after all this time.